HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Chlorothiazide

HCID 2720
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
58-94-6
Standard SMILES
NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O
InChIKey
JBMKAUGHUNFTOL-UHFFFAOYSA-N
Molecular formula
C7H6ClN3O4S2
Average molar mass
295.7 g/mol
Monoisotopic mass
294.9488257

Overview

Crystals; white powder. (NTP, 1992)

Names & identifiers

Preferred name
Chlorothiazide
IUPAC
6-chloro-1,1-dioxo-4H-1λ6,2,4-benzothiadiazine-7-sulfonamide
English name
Chlorothiazide
Molecular formula
C7H6ClN3O4S2
Molecular weight
295.72

Names & synonyms

chlorothiazide58-94-6DiurilChlorthiazideChlorothiazidChlortiazidChlotrideFlumenChlorosalChloruritClotrideDiuresal
Show more names
ThiazideHydrochlorothiazide Impurity AUrinexDiupres
DiurilixSaluretilWarduzideAlureneDiuriteDiutridMinzilSalisan

Database identifiers

CAS
58-94-6
PubChem CID
2720
DTXSID
DTXSID0022800
ChEMBL
CHEMBL842
ChEBI
CHEBI:3640
UNII
77W477J15H
EC Number
200-404-9

Properties

Computed structural propertiesFilling in

XLogP
-0.2
Topological polar surface area
135 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
1
Heavy atoms
17
Formal charge
0
Complexity
532

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Metabolite of Hydrochlorthiazide

SpringerMaterials PropertiesCrystal structure
LogP · 3 items

log Kow = -0.24

-0.5

-0.1

OdorODORLESS
Color/Form · 2 items

Crystals

WHITE OR PRACTICALLY WHITE

Solubility · 5 items

less than 1 mg/mL at 67.1 °F (NTP, 1992)

SOL IN WATER: 0 G/L @ PH 4, 0.65 G/L @ PH 7; SOL IN ALKALINE AQ SOLN

FREELY SOL IN DIMETHYLFORMAMIDE & DIMETHYL SULFOXIDE; SLIGHTLY SOL IN METHANOL & PYRIDINE; PRACTICALLY INSOL IN ETHER, BENZENE, & CHLOROFORM

3.98e-01 g/L

>44.4 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 4 items

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Thiazide Diuretics

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Antihypertensive medicines

Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
DecompositionWhen heated to decomposition it emits very toxic fumes of sulfoxides, nitroxides, and /hydrogen chloride/.
Melting Point · 4 items

648 to 649 °F (Decomposes) (NTP, 1992)

342.5-343

Decomposes at 342.5-343 °C

350 °C

Physical Description · 2 items

Crystals; white powder. (NTP, 1992)

Solid

Dissociation Constants · 2 items

6.85

pKa1 = 6.85; pKa2 = 9.45

Physicochemical properties

Melting point
342 · 342-343°C
Boiling point
608.8 · 608.8±65.0 °C(Predicted)
Density
1.7303 · 1.7303 (rough estimate)
refractive index
1.61 · 1.6100 (estimate)
storage temp.
2 · 2-8°C
solubility
DMSO (Slightly), Methanol (Very Slightly, Heated)
form
Solid
pka
6.85 · 6.85, 9.45(at 25℃)
color
White to Off-White
Water Solubility
0.1 g/100 · <0.1 g/100 mL at 19.5 ºC
Merck
14 · 14,2168
BCS Class
4 · 4
Stability
Stable. Incompatible with strong oxidizing agents.
Major Application
pharmaceutical (small molecule)
InChI
1S/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H,10,11)(H2,9,12,13)
InChIKey
JBMKAUGHUNFTOL-UHFFFAOYSA-N
SMILES
O=S(C1=C2C=C(Cl)C(S(N)(=O)=O)=C1)(NC=N2)=O
LogP
-0.24 · -0.240
CAS DataBase Reference
58 · 58-94-6(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
77 W477J15H · 77W477J15H
ATC code
3 AA04,C03AH01 · C03AA04,C03AH01
NIST Chemistry Reference
Chlorothiazide(58-94-6)
EPA Substance Registry System
Chlorothiazide (58-94-6)
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
8 · GHS08
Signal word
Danger
Hazard statements
317 · H317-H334
Precautionary statements
261 · P261-P272-P280-P284-P302+P352-P304+P340+P312
Hazard Codes
Xn
Risk Statements
42 · 42/43-20/21/22
Safety Statements
36 · 36
WGK Germany
2 · 2
RTECS
9450000 · DK9450000
TSCA
TSCA listed
HS Code
2935904000 · 2935904000
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
1 Skin · Resp. Sens. 1Skin Sens. 1
Hazardous Substances Data
58 · 58-94-6(Hazardous Substances Data)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H317 (99.7%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 344 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Other Safety InformationIMAP assessments - 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide: Human health tier I assessment
Fire HazardsFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)
Health Hazards · 1 item

SYMPTOMS: Symptoms of exposure to this compound may include skin and mucous membrane irritation; pancreatitis, depression of the formed elements of the blood; purpura, photosensitive dermatitis, necrotizing vasculitis, hyperglycemia, aggravation of diabetes mellitus; exacerbation of renal and/or hepatic insufficiency; lethargy, potassium loss, hyperglycemia, hyperuricemia, coma, chloride loss, lethargy, muscle cramps, acidosis, skin rash, salivary gland obstruction, psychosis, convulsions, leukopenia, jaundice, excessive amount of calcium in the blood, acute glomerulonephritis, anorexia, nausea, vomiting, cramping, diarrhea, dizziness, constipation, vertigo, paresthesis, headache, xanthopsia, hemolytic anemia, urticuria, fever, respiratory distress, including pneumonitis and pulmonary edema, anaphylactic reactions, glycosuria, muscle spasm, weakness, transient blurred vision and restlessness.

FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Reactive GroupAmines, Phosphines, and Pyridines
Reactivity ProfileAlkaline aqueous solutions will decompose on standing or heating (NTP, 1992).
Air and Water ReactionsInsoluble in water.
Hazard Classes and CategoriesSkin Sens. 1 (99.7%)

Safety & protection

Fire FightingFires involving this material can be controlled with a carbon dioxide, dry chemical or Halon extinguisher. (NTP, 1992)
First Aid · 1 item

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 item

SMALL SPILLS AND LEAKAGE: If you spill this chemical, FIRST REMOVE ALL SOURCES OF IGNITION, then dampen the solid spill material with toluene, then transfer the dampened material to a suitable container. Use absorbent paper dampened with toluene to pick up any remaining material. Your contaminated clothing and absorbent paper should be sealed in a vapor-tight plastic bag for eventual disposal. Solvent-wash all contaminated surfaces with toluene followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Personal Protective Equipment (PPE) · 1 item

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Toxicology

Interactions · 5 items

...IN DOG PRELOADED WITH SODIUM BICARBONATE, URINE EXCRETED AFTER ADMIN OF A THIAZIDE CONTAINS RELATIVELY MORE BICARBONATE THAN CHLORIDE. /BENZOTHIADIAZIDES/

USE OF ENTERIC-COATED COMBINATIONS OF POTASSIUM CHLORIDE & THIAZIDE... ASSOCIATED WITH A HIGH INCIDENCE OF ULCERATION OF DISTAL JEJUNUM OF ILEUM. /BENZOTHIADIAZIDES/

Concurrent use of thiazide diuretics with amiodarone may lead to an increased risk of arrhythmias associated with hypokalemia. /Thiazide diuretics/

Effects /of coumarin- or indandione-derivative anticoagulants/ may be decreased when used concurrently with thiazide diuretics as a result of reduction of plasma volume leading to concentration of procoagulant factors in the blood; in addition, diuretic-induced improvement of hepatic function resulting in increased procoagulant factor synthesis; dosage adjustments may be necessary. /Thiazide diuretics/

For more Interactions (Complete) data for CHLOROTHIAZIDE (16 total), please visit the HSDB record page.

Milk ConcentrationsChlorothiazide is excreted into breast milk in low concentrations.
Human Toxicity Excerpts · 5 items

TWO SMALL CHILDREN...INGESTED TOTAL DOSE OF 15 G CHLOROTHIAZIDE BETWEEN THEM, PRESENTED WITH LETHARGY WHICH PROGRESSED TO DEEP COMA WITHIN 12 HR. BOTH RECOVERED WITHOUT SEQUELAE, & NEITHER CHILDREN EXHIBITED OBJECTIVE EVIDENCE OF FLUID OR ELECTROLYTE DISORDER. ...22-MO-OLD CHILD WHO INGESTED 3 G EXHIBITED LETHARGY.

FETAL OR NEONATAL EFFECT IS THROMBOCYTOPENIA. /FROM TABLE/

Maternal and fetal deaths in two cases of acute hemorrhagic pancreatitis were attributed to the use of chlorothiazide in the second and third trimesters.

In addition to diuresis and resultant dehydration, overdosage of thiazides may produce lethargy, nausea, weakness, and electrolyte imbalance; lethargy may progress to coma within a few hours with minimal depression of respiratory and cardiovascular function and without evidence of dehydration or serum electryolye change. The mechanism of thiazide-induced CNS depression is unknown. GI irritation and hypermotility may occur, and temporary elevation of the BUN has been reported. Serum electrolyte changes (e.g., hypokalemia, hypochloremia, hyponatremia) may occur, especially in patients with impaired renal function. /Thiazides/

May suppress lactation, but compatible /SRP: with breast feeding/. /Thiazide diuretics, from table/

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Chlorothiazide

vLess-DILI-concern

2

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Non-Human Toxicity Excerpts · 2 items

DOSES OF UP TO 5 G/KG /IN MONKEYS/ BY GAVAGE PRODUCED ONLY A TRANSIENT LETHARGY OF A MODERATE DEGREE.

HYPOCHLOREMIA HAS OCCURRED IN SOME DOGS WITH INCR BICARBONATE RETENTION & ALKALOSIS.

Antidote and Emergency TreatmentThiazide diuretic overdose should be treated by immediate evacuation of the stomach followed by supportive symptomatic treatment and monitoring of serum electrolyte concentrations and renal function. /Thiazide diuretic/
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Non-Human Toxicity Values · 5 items

LD50Rat oral 10 g/kg

LD50 Rat ip 1386 mg/kg

LD50 Rat iv 200 mg/kg

LD50 Mouse oral 8 g/kg

For more Non-Human Toxicity Values (Complete) data for CHLOROTHIAZIDE (7 total), please visit the HSDB record page.

EPA Human Health Benchmarks for Pharmaceuticals · 6 items

Chlorothiazide

11.7

49.3

The usual adult dosage is 0.5 g to 1 g once or twice a day.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 500 mg/day, Lowest Therapeutic Dose (LTD): 6.3 mg/kg-day, and Screening Dose: 0.002 mg/kg-day.

21-Jan-20

Regulatory information

FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Safety data

wgk
2
tsca
TSCA listed
rtecs
DK9450000
hs_code
2935904000
risk_code
42/43-20/21/22
Signal word
Danger
Symbol(GHS)
GHS08
hazard_code
Xn
safety_code
36
Storage Class
11 - Combustible Solids
Hazard statements
H317-H334
Hazard Classifications
Resp. Sens. 1Skin Sens. 1
Precautionary statements
P261-P272-P280-P284-P302+P352-P304+P340+P312
Hazardous Substances Data
58-94-6(Hazardous Substances Data)

Chemistry & industry

Pharmacology

ATC Code · 2 items

C - Cardiovascular system

QC - Cardiovascular system

Protein BindingApproximately 40% bound to plasma proteins.
Pharmacodynamics · 1 item

Like other thiazides, chlorothiazide promotes water loss from the body (diuretics). It inhibits Na<sup>+</sup>/Cl<sup>-</sup> reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue. Chlorothiazide affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosages, all thiazides are approximately equal in their diuretic efficacy. Chlorothiazide increases excretion of sodium and chloride in approximately equivalent amounts. Natriuresis may be accompanied by some loss of potassium and bicarbonate. After oral doses, 10-15 percent of the dose is excreted unchanged in the urine. Chlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk.

Mechanism of Action · 6 items

As a diuretic, chlorothiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like chlorothiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of chlorothiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle.

THE MECHANISM BY WHICH THIAZIDE DIURETICS LOWER BLOOD PRESSURE HAS NOT BEEN FIRMLY ESTABLISHED. /THIAZIDE DIURETICS/

...INDICATED THAT BENZOTHIADIAZIDES HAVE A DIRECT EFFECT ON RENAL TUBULAR TRANSPORT OF SODIUM & CHLORIDE INDEPENDENT OF CARBONIC ANHYDRASE INACTIVATION. /THIADIAZIDES/

IRRESPECTIVE OR ULTIMATE MECHANISM, IT APPEARS THAT DIURETIC THIAZIDES RELAX PERIPHERAL ARTERIOLAR SMOOTH MUSCLE. /THIAZIDES/

CARBONIC ANHYDRASE INHIBITOR WITHOUT EXCESSIVE BICARBONATE EXCRETION WITH RESULTANT ACIDOSIS.

For more Mechanism of Action (Complete) data for CHLOROTHIAZIDE (10 total), please visit the HSDB record page.

Biological Half-Life · 2 items

45-120 minutes

Half-life is 1.5 hours. /From Table/

Metabolism/Metabolites · 2 items

Chlorothiazide is not metabolized but is eliminated rapidly by the kidney.

...CHLOROTHIAZIDE...METABOLICALLY STABLE & FOLLOWING IV ADMIN TO...HUMANS...EXCRETED UNCHANGED IN URINE.

FDA Pharmacological Classification · 6 items

77W477J15H

CHLOROTHIAZIDE

Physiologic Effects [PE] - Increased Diuresis

Established Pharmacologic Class [EPC] - Thiazide Diuretic

Chemical Structure [CS] - Thiazides

Chlorothiazide is a Thiazide Diuretic. The physiologic effect of chlorothiazide is by means of Increased Diuresis.

MeSH Pharmacological Classification · 3 items

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Agents that promote the excretion of urine through their effects on kidney function.

Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.

Absorption, Distribution and Excretion · 6 items

Rapidly absorbed following oral administration.

Chlorothiazide is not metabolized but is eliminated rapidly by the kidney. After oral doses, 10 to 15 percent of the dose is excreted unchanged in the urine. Chlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk.

CHLOROTHIAZIDE IS DISTRIBUTED THROUGHOUT EXTRACELLULAR SPACE & DOES NOT ACCUMULATE IN TISSUES OTHER THAN THE KIDNEY.

ALL OF THE THIAZIDE-LIKE DRUGS CROSS THROUGH THE PLACENTA.

IN NEPHRECTOMIZED ANIMAL, CHLOROTHIAZIDE MAY BE EXCRETED IN THE BILE; IT DOES NOT UNDERGO METABOLIC ALTERATION.

CHLOROTHIAZIDE IN A 1.1 FETAL/MATERNAL CONCN RATIO REQUIRES 60 MIN TO APPEAR IN FETUS... /FROM TABLE/

Cellular LocationsCytoplasm
Metabolite PathwaysChlorothiazide Action Pathway

Uses & manufacturing

Uses · 2 items

Diuretic /sodium salt/

MEDICATION (VET):

U.S. Imports · 2 items

(1975) 7.5X10+6 GRAMS (PRINCPL CUSTMS DISTS)

(1976) 1.73X10+7 GRAMS (PRINCPL CUSTMS DISTS)

U.S. Production · 2 items

(1972) GREATER THAN 4.54X10+5 GRAMS

(1975) 4.54X10+5 GRAMS

Consumption PatternsESSENTIALLY 100% AS A MEDICINAL (1976)
Methods of Manufacturing · 2 items

REACTION OF 3-CHLOROANILINE WITH CHLOROSULFONIC ACID FOLLOWED BY TREATMENT WITH AMMONIA TO GIVE 3-CHLORO-4,6-DISULFONAMIDOANILINE WHICH IS THEN HEATED WITH FORMIC ACID

NOVELLO, SPRAGUE, J AM CHEM SOC 79, 2058 (1957); NOVELLO, HINKLEY, US PATENTS 2,809,194; 2,937,169 (1957, 1960, BOTH TO MERCK & CO).

Use Classification · 2 items

Pharmaceuticals -> Diuretics -> Transformation products

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

General Manufacturing Information · 2 items

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide: ACTIVE

A 3 DAY TREATMENT WITHDRAWAL PERIOD SHOULD BE OBSERVED TO AVOID UNTOWARD EFFECTS IN PEOPLE FROM CONSUMING MEAT & ESPECIALLY MILK FROM TREATED ANIMALS.

Applications · 3 items

DescriptionChlorothiazide is a first-in-class thiazide diuretic initially discovered from its ability to inhibit carbonic anhydrase in vitro. As an antihypertensive agent, this thiazide increases renal excretion of sodium, potassium, chloride, and bicarbonate ions by inhibiting tubular reabsorptive mechanisms.

UsesChlorthiazide is a diuretic that causes the body to excrete excess fluid. This drug exhibits strong diuretic action during both acidosis and alkalosis. It is used for arterial hypertension, in edematous syndromes of various genesis, congestive effects in cardiovascular insufficiency, nephrosis and nephritis, and toxicosis. It is especially recommended for hypertonic illnesses. It lowers intraocular pressure in a number of cases.

General DescriptionCrystals; white powder.

Upstream & downstream products

Upstream raw materials

Formic acid4-Amino-6-chlorobenzene-1,3-disulfonamide

Downstream products

Hydrochlorothiazide
Additional notes · 1 item

DefinitionChEBI: Chlorothiazide is 4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension. It has a role as a diuretic and an antihypertensive agent.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes